Skip to main navigation Skip to search Skip to main content

Susceptibility mutations for ischemic heart disease

7 Citations (Scopus)

Abstract

In The Copenhagen City Heart Study, apolipoprotein B Arg3500Gln and Arg3531Cys increased plasma cholesterol 41% and 0%, lipoprotein lipase Gly188Glu, Asn291Ser, and Asp9Asn increased plasma triglycerides 42%, 13% (women only), and 13% (men only), and angiotensin converting enzyme DD increased plasma ACE activity 57%. Risk of ischemic heart disease for these mutations was sevenfold, unchanged, fivefold, twofold (women only), twofold (men only), and unchanged, respectively, compared with threefold for diabetes mellitus. The fraction of ischemic heart disease in the population at large attributed to these mutations was 0.5%, 0%, 0.3%, 5% (women only), 3% (men only), and 0%, respectively, compared with 7% for diabetes mellitus.

Original languageEnglish
JournalCurrent Atherosclerosis Reports
Volume1
Issue number2
Pages (from-to)108-14
Number of pages7
ISSN1523-3804
DOIs
Publication statusPublished - Sept 1999
Externally publishedYes

Keywords

  • Apolipoproteins B/genetics
  • Cholesterol/blood
  • Coronary Disease/blood
  • Female
  • Genetic Predisposition to Disease
  • Humans
  • Lipoprotein Lipase/genetics
  • Male
  • Mutation
  • Peptidyl-Dipeptidase A/blood
  • Triglycerides/blood

Fingerprint

Dive into the research topics of 'Susceptibility mutations for ischemic heart disease'. Together they form a unique fingerprint.

Cite this